Results 111 to 120 of about 14,948 (182)

Trehalose Attenuates In Vitro Neurotoxicity of 6-Hydroxydopamine by Reducing Oxidative Stress and Activation of MAPK/AMPK Signaling Pathways. [PDF]

Int J Mol Sci
Stevanovic D, Vucicevic L, Misirkic-Marjanovic M, Martinovic T, Mandic M, Harhaji-Trajkovic L, Trajkovic V.   +6 more
europepmc   +1 more source

Correction to "P90RSK and Nrf2 Activation via MEK1/2-ERK1/2 Pathways Mediated by Notoginsenoside R2 to Prevent 6-Hydroxydopamine-Induced Apoptotic Death in SH-SY5Y Cells". [PDF]

Evid Based Complement Alternat Med
europepmc   +1 more source

Phosphodiesterase inhibition and Gucy2C activation enhance tyrosine hydroxylase Ser40 phosphorylation and improve 6-hydroxydopamine-induced motor deficits. [PDF]

Cell Biosci
Douma EH, Stoop J, Lingl MVR, Smidt MP, van der Heide LP.   +4 more
europepmc   +1 more source

Characterization of graded 6-Hydroxydopamine unilateral lesion in medial forebrain bundle of mice. [PDF]

Sci Rep
Cui J, Zhao D, Xu M, Li Z, Qian J, Song N, Wang J, Xie J.   +7 more
europepmc   +1 more source

Soft Corals-derived Dihydrosinularin Attenuates Neuronal Apoptosis in 6-hydroxydopamine-induced Cell Model of Parkinson's Disease by Regulating the PI3K Pathway. [PDF]

Curr Med Chem
Wen ZH, Chiu YJ, Yang SN, Huang TY, Feng CW, Chen NF, Sung CS, Chen WF.   +7 more
europepmc   +1 more source

The Absence of Gastrointestinal Redox Dyshomeostasis in the Brain-First Rat Model of Parkinson's Disease Induced by Bilateral Intrastriatal 6-Hydroxydopamine. [PDF]

Mol Neurobiol
Homolak J, Joja M, Grabaric G, Schiatti E, Virag D, Babic Perhoc A, Knezovic A, Osmanovic Barilar J, Salkovic-Petrisic M.   +8 more
europepmc   +1 more source

Effects of Unilateral High Frequency Stimulation of the Subthalamic Nucleus on Risk-avoidant Behavior in a Partial 6-hydroxydopamine Model of Parkinson's Disease. [PDF]

J Integr Neurosci
Hillan SG, Asp AJ, Pramanik LB, Mukerjee AA, Mulder CB, Lujan WD, Silvernail JL, Chang SY, Boschen SL, Lujan JL.   +9 more
europepmc   +1 more source

Role of Nitric Oxide Modulators in Neuroprotective Effects of Mangiferin in 6-Hydroxydopamine-induced Parkinson's Disease in Rats. [PDF]

Ann Neurosci
Tiwari PC, Chaudhary MJ, Pal R, Nath R.
europepmc   +1 more source

Sustained Systemic Antioxidative Effects of Intermittent Theta Burst Stimulation beyond Neurodegeneration: Implications in Therapy in 6-Hydroxydopamine Model of Parkinson's Disease. [PDF]

Antioxidants (Basel)
Zeljkovic Jovanovic M, Stanojevic J, Stevanovic I, Ninkovic M, Nedeljkovic N, Dragic M.   +5 more
europepmc   +1 more source

The effect of inhibiting hindbrain A2 noradrenergic neurons by 6-Hydroxydopamine on lipopolysaccharide-treated male rats autistic animal model. [PDF]

Saudi Pharm J
Alhamami HN, Albogami AM, Algahtani MM, Alqinyah M, Alanazi WA, Alasmari F, Alhazzani K, Alanazi AZ, Alassmrry YA, Alhamed AS.   +9 more
europepmc   +1 more source